20-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with Glioma in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Chen, X; Duan, C; Li, Y; Liu, Y; Qin, T; Wang, C; Yang, J; Zhang, J; Zhou, X | 1 |
| Awwad, K; Corada, M; Dejana, E; Devraj, K; Fisslthaler, B; Fleming, I; Liebner, S; Minardi, SP; Plate, KH; Reis, M; Ziegler, N | 1 |
| Arbab, AS; Edwards, PA; Falck, JR; Guo, AM; Lehman, NL; Roman, RJ; Scicli, AG; Scicli, GM; Sheng, J | 1 |
| Edwards, PA; Falck, JR; Guo, M; Roman, RJ; Scicli, AG | 1 |
4 other study(ies) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and Glioma
| Article | Year |
|---|---|
Inhibition of CYP4A by a novel flavonoid FLA-16 prolongs survival and normalizes tumor vasculature in glioma.
Topics: Angiogenesis Inhibitors; Animals; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chalcones; Culture Media, Conditioned; Cytochrome P-450 CYP4A; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Endothelial Progenitor Cells; Flavonoids; Glioma; Humans; Hydroxyeicosatetraenoic Acids; Macrophages; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Neovascularization, Pathologic; Paracrine Communication; Pericytes; Rats, Wistar; Time Factors; Transforming Growth Factor beta; Tumor Burden; Tumor Microenvironment; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2017 |
β-Catenin Is Required for Endothelial Cyp1b1 Regulation Influencing Metabolic Barrier Function.
Topics: Animals; Basic Helix-Loop-Helix Transcription Factors; beta Catenin; Blood-Brain Barrier; Brain Neoplasms; Cadherins; Capillary Permeability; Chromatin Immunoprecipitation; Cytochrome P-450 CYP1B1; Dose-Response Relationship, Drug; Endothelial Cells; Female; Gene Expression Regulation; Glioma; Histones; Hydroxyeicosatetraenoic Acids; Male; Mice; Mice, Nude; Models, Biological; Neoplasm Transplantation; Receptors, Aryl Hydrocarbon; RNA, Messenger; Wnt Signaling Pathway | 2016 |
Expression of CYP4A1 in U251 human glioma cell induces hyperproliferative phenotype in vitro and rapidly growing tumors in vivo.
Topics: Arachidonic Acid; Cell Adhesion; Cell Cycle; Cell Proliferation; Cytochrome P-450 CYP4A; Extracellular Signal-Regulated MAP Kinases; Glioma; Humans; Hydroxyeicosatetraenoic Acids; Magnetic Resonance Imaging; Neoplastic Stem Cells; Oxidative Stress; Phenotype; Signal Transduction; Vascular Endothelial Growth Factor A | 2008 |
Human U251 glioma cell proliferation is suppressed by HET0016 [N-hydroxy-N'-(4-butyl-2-methylphenyl)formamidine], a selective inhibitor of CYP4A.
Topics: Amidines; Antineoplastic Agents; Arachidonic Acid; Blotting, Western; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP4A; DNA Fragmentation; Enzyme Inhibitors; ErbB Receptors; Flow Cytometry; Glioma; Humans; Hydroxyeicosatetraenoic Acids; In Situ Nick-End Labeling; Mitogen-Activated Protein Kinase 1; Mitosis; Reverse Transcriptase Polymerase Chain Reaction; RNA, Neoplasm; Signal Transduction; Thymidine | 2005 |